After a former Insys Therapeutics sales rep admitted she had paid kickbacks to doctors to prescribe the company's sprayed cancer pain opioid fentanyl for…

It didn’t take long for the backlash to start after Mylan crafted an EpiPen patient-assistance plan to calm the pricing crisis. Critics pounced, calling the…

Chairman Zhou Jie resigns just three months after taking on the role.

Sarah Jessica Parker just dumped Mylan because of its EpiPen price hikes. She had signed on in May to headline Mylan’s “Anaphylaxis for Reel” awareness push.

The power of a Hillary Clinton tweet showed again Wednesday, when the presidential candidate spoke on drug price, raising fears of government action. Biotech…

Amid a frenzy of criticism for the price of EpiPen, Mylan swiftly expanded its co-pay help for patients. But it did not adjust the actual price of a med that’s…

BeiGene has been cleared to start Chinese trials of its PARP inhibitor BGB-290, one of a portfolio of homegrown drugs that aims to challenge Western dominance…

Bad news for Teva, much-needed good news for the embattled Mylan: The U.S. Patent and Trademark office’s review board struck down two patents on Teva’s new…